Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Return on Sales (2016 - 2025)

Historic Return on Sales for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to 0.02%.

  • International Stem Cell's Return on Sales rose 800.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.02% for FY2024, which is 800.0% up from last year.
  • According to the latest figures from Q3 2025, International Stem Cell's Return on Sales is 0.02%, which was up 800.0% from 0.05% recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Return on Sales peaked at 0.05% during Q2 2025, and registered a low of 0.36% during Q1 2021.
  • In the last 5 years, International Stem Cell's Return on Sales had a median value of 0.07% in 2023 and averaged 0.1%.
  • Per our database at Business Quant, International Stem Cell's Return on Sales skyrocketed by 3600bps in 2022 and then tumbled by -2500bps in 2023.
  • Over the past 5 years, International Stem Cell's Return on Sales (Quarter) stood at 0.2% in 2021, then skyrocketed by 106bps to 0.01% in 2022, then plummeted by -2204bps to 0.24% in 2023, then surged by 102bps to 0.0% in 2024, then soared by 390bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.05% for Q2 2025, and 0.12% during Q1 2025.